The Drug Eluting Stents Center

Filter Your Results

 

News

 

Boston Scientific's Eluvia DES Evaluated for Femoropopliteal Lesions in IMPERIAL Trial

September 22, 2018 -- Boston Scientific announced 12-month data from the IMPERIAL trial evaluating the company's Eluvia paclitaxel-eluting vascular stent system versus the…

Bioresorbable Stent Technology for Femoropopliteal Disease Treatment: Where Do We Stand?

Sabine Steiner, MD; Andrej Schmidt, MD; and Dierk Scheinert, MD

September 2018—Appraising the current literature on bioresorbable technology use in the SFA, what can be learned from the coronary experience, and the future of bioresorbable stents in this anatomy.

Pivotal Trial Begins for Boston Scientific's Saval BTK DES to Treat CLI

September 6, 2018 -- Boston Scientific Corporation announced that it has enrolled the first patient in the SAVAL pivotal trial to evaluate clinical outcomes of the company'…

DEBATE in SFA Study Compares Nitinol Bare-Metal Stents With or Without Cilostazol Versus DES

August 29, 2018 -- In Circulation: Cardiovascular Interventions, Takashi Miura, MD, et al published findings from DEBATE in SFA, a study of drug-eluting stent (DES) versus nit…

Cook Medical Introduces 140-mm–Long Zilver PTX Stent

August 8, 2018 -- Cook Medical has introduced the 140-mm -- long Zilver PTX paclitaxel-eluting peripheral stent in both 6-mm and 7-mm diameters in the United States. Zilv…

DANCE Trial Evaluates Adventitial Drug Delivery of Dexamethasone to Treat Femoropopliteal PAD Adjunctive to Endovascular Therapy

May 30, 2018 -- Twelve-month results from the DANCE clinical trial were published by Mahmood K. Razavi, MD, et al in Journal of the American College of Cardiology (JACC): Card…

Inert Technology: Actively Making a Difference in Drug-Eluting Stent Designs

November 2017—QualiMed’s sirolimus-eluting coronary stent is available under CE Mark only and is not approved in the United States. First-generation drug-eluting stents (DESs) deli…

Results Published From Cook Medical's Zilver PTX Japan Postmarket Surveillance Study

November 8, 2017 -- Results from the Zilver PTX Japan postmarket surveillance study of the Zilver PTX paclitaxel-eluting stent (Cook Medical) were published by Stefano Cipolla…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.